• Home
  • News
  • [Member in The News] ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index

[Member in The News] ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index

December 16, 2021 8:17 AM | EMA Staff (Administrator)

ATLANTA & NEW YORK--(BUSINESS WIRE)-- Intercontinental Exchange, Inc. (NYSE: ICE), a leading global provider of data, technology and market infrastructure, today announced the annual reconstitution of the ICE Biotechnology Index (ICEBIO), which is effective before the open of trading on Monday, December 20, 2021.

The ICE Biotechnology Index tracks the performance of qualifying U.S. listed biotechnology companies classified within the Biotechnology Sub-Industry Group of the ICE Uniform Sector Classification schema, which is a multi-asset class industry classification taxonomy developed by ICE. The index includes companies that are engaged in the research and development of therapeutic treatments but are not focused on the commercialization and mass production of pharmaceutical drugs. The index also includes companies that are engaged in the production of tools or systems that enable biotechnology processes.

Read more: https://ir.theice.com/press/news-details/2021/ICE-Announces-Annual-Reconstitution-Changes-in-the-ICE-Biotechnology-Index/default.aspx

Powered by Wild Apricot Membership Software